IRONWOOD PHARMACEUTICALS, INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $11.36 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2022-02-18
- IRONWOOD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2019-06-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2019-03-31 was $11.36M.
- IRONWOOD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2019 was $11.36M, a 3.76% decline from fiscal 2018.
- IRONWOOD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2018 was $11.81M, a 62.04% increase from fiscal 2017.
- IRONWOOD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2017 was $7.29M.
- IRONWOOD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2010 was -$5.97M.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $0.00 derived: sum of 2 quarters · filed 2022-02-18 | $0.00 derived: sum of 3 quarters · filed 2022-02-18 | $11.36M 10-K · filed 2022-02-18 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $11.36M 10-Q · filed 2020-11-05 | $15.26M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $11.36M 10-Q · filed 2020-08-06 | $15.26M derived: sum of 3 quarters · filed 2021-02-17 | $17.87M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | $11.36M 10-Q · filed 2020-05-06 | $15.26M derived: sum of 2 quarters · filed 2021-02-17 | $17.87M derived: sum of 3 quarters · filed 2021-02-17 | |
| 2018-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $6.50M derived: sum of 2 quarters · filed 2021-02-17 | $11.81M 10-K · filed 2021-02-17 | |
| 2018-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $7.91M 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | $5.30M 10-Q · filed 2019-07-30 | |||
| 2017-12-31 | $7.29M 10-K · filed 2020-02-13 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | -$3.53M derived: sum of 2 quarters · filed 2013-02-21 | -$5.97M 10-K · filed 2013-02-21 | |
| 2010-09-30 | -$3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$5.97M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$2.44M 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | -$11.51M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |